Annual Drug Patent Expirations for RELYVRIO
Relyvrio is a drug marketed by Amylyx and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has thirty-two patent family members in eighteen countries.
The generic ingredient in RELYVRIO is sodium phenylbutyrate; taurursodiol. One supplier is listed for this compound. Additional details are available on the sodium phenylbutyrate; taurursodiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
